1. Home
  2. AIRS vs GOSS Comparison

AIRS vs GOSS Comparison

Compare AIRS & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AIRS

AirSculpt Technologies Inc.

HOLD

Current Price

$5.35

Market Cap

328.7M

Sector

Health Care

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$0.16

Market Cap

41.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIRS
GOSS
Founded
2012
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
328.7M
41.7M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
AIRS
GOSS
Price
$5.35
$0.16
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$4.19
AVG Volume (30 Days)
812.3K
16.5M
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$151,818,000.00
$48,471,000.00
Revenue This Year
$5.19
N/A
Revenue Next Year
$5.32
$201.64
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.51
$0.14
52 Week High
$12.00
$3.87

Technical Indicators

Market Signals
Indicator
AIRS
GOSS
Relative Strength Index (RSI) 60.95 30.33
Support Level $2.40 $0.16
Resistance Level $5.79 $0.36
Average True Range (ATR) 0.43 0.02
MACD -0.09 0.00
Stochastic Oscillator 59.28 24.39

Price Performance

Historical Comparison
AIRS
GOSS

About AIRS AirSculpt Technologies Inc.

AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).

Share on Social Networks: